4th Annual Gayle Brinkenhoff Breast Cancer Symposium

TUESDAY, NOVEMBER 14, 2017

8:00 – 8:50 AM   REGISTRATION / BREAKFAST

8:50 – 9:00 AM  Welcome & Announcements

9:00 – 9:50 AM  KEYNOTE ADDRESS: Resistance to Endocrine Therapy in ER+ Breast Cancer: Insights from Bedside to Bench Studies
Carlos L. Arteaga, MD – UT Southwestern Harold C. Simmons Cancer Center, Dallas, TX

9:50 – 10:30 AM  The Diagnosis and Treatment of DNA Repair Defective Breast Cancers
Simon N. Powell, MD, PhD – Memorial Sloan Kettering Cancer Center, New York, NY

10:30 – 10:40 AM MORNING BREAK

10:40 – 11:20 AM Delivering on the Promise of Personalized Molecular Medicine
Gordon B. Mills, MD, PhD – MD Anderson Cancer Center, Houston, TX

11:20 – 12:00 PM  Therapy Resistant Recurrence in Breast Cancer
Suwon Kim, PhD – Translational Genomics Research Institute (TGen), Phoenix, AZ

12:00 – 1:00 PM  LUNCH

1:00 – 1:40 PM   The Role of Microenvironment in Susceptibility to Age-Related Breast Cancers
Mark LaBarge, PhD – City of Hope, Duarte, CA

1:40 – 2:20 PM   Early Detection: How Molecular Pathology Can Change the Mortality Rates of Triple Negative Breast Cancer Patients
Christopher Sistrunk, PhD – City of Hope, Duarte, CA

2:20 – 2:40 PM  AFTERNOON BREAK

2:40 – 3:20 PM  HsRAD52: An Occult Factor in Tumor Suppression
Adam Bailis, PhD – City of Hope, Duarte, CA

3:20 – 4:00 PM  Panel Discussion
Moderator: Victoria Seewaldt, MD – City of Hope, Duarte, CA

4:00 PM   ADJOURN